Log in to save to my catalogue

Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult...

Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1eaff1b28fcb4da8a6c901126368c6c5

Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study

About this item

Full title

Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study

Publisher

England: BioMed Central Ltd

Journal title

BMC public health, 2021-09, Vol.21 (1), p.1731-1731, Article 1731

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Community-acquired pneumonia is an important cause of morbidity and mortality in adults. Approximately one-third of pneumonia cases can be attributed to the pneumococcus. Pneumococcal conjugate vaccines (PCVs) protect against colonisation with vaccine-type serotypes. The resulting decrease in transmission of vaccine serotypes leads to large indirec...

Alternative Titles

Full title

Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1eaff1b28fcb4da8a6c901126368c6c5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1eaff1b28fcb4da8a6c901126368c6c5

Other Identifiers

ISSN

1471-2458

E-ISSN

1471-2458

DOI

10.1186/s12889-021-11776-8

How to access this item